It's worse than we thought: the US market for novel Gram-negative antibiotics

Lancet Infect Dis. 2020 Sep;20(9):1009-1010. doi: 10.1016/S1473-3099(20)30640-X.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Bacterial Agents*
  • Hospitals*
  • Needs Assessment
  • Retrospective Studies

Substances

  • Anti-Bacterial Agents